Ministry of Industry and Trade proposed limiting the admission of foreign drugs in public procurements

18 November 2021

Ministry of Industry and Trade prepared a draft on amending the Regulations of the Russian Government No. 1289 of 30 November 2015. Under the draft the drugs from the List of Strategically Important Drugs produced in a foreign country shall be rejected to supply by the customer if there is at least one offer to supply a drug produced (all manufacturing stages) exclusively in the territory of the Eurasian Union member states.